Vimarsana
Biggest News Aggregation in the World

Patient With News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patient With. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patient With Today - Breaking & Trending Today

Best Approaches to Switching Therapies for a Patient With Myelofibrosis - Vimarsana News

Best Approaches to Switching Therapies for a Patient With Myelofibrosis

Reasons to switch JAK inhibitors include worsening blood counts and insufficient symptom or spleen response at maximum doses, with the goal of avoiding gaps in treatment by stopping one JAK inhibitor when ready to start the next to prevent symptom rebound while still allowing for potential increased efficacy from an alternative mechanism of action.

75% Of U.S. Women Executives Have Impostor Syndrome - Vimarsana News

75% Of U.S. Women Executives Have Impostor Syndrome

Many women in senior leadership face self-doubt, also known as impostor syndrome. Why is this the case, and how can female business leaders overcome self-doubt?

Source: forbes.com
Significant Demographic and Clinical Differences Observed in Patterns Between NMOSD and MS - Vimarsana News

Significant Demographic and Clinical Differences Observed in Patterns Between NMOSD and MS

A recent meta-analysis revealed significant differences in characteristic between patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS), highlighting the need for enhanced tools to differentiate between these diseases for early and accurate diagnosis.

Source: ajmc.com
Distress Screening Is Needed — But Uncommon — Among Cancer Caregivers - Vimarsana News

Distress Screening Is Needed — But Uncommon — Among Cancer Caregivers

Most oncology clinics screen for psychosocial distress among patients with cancer, but the same can’t be said for their caregivers, recent research found.

Considerations When Deciding Between an IO/TKI and IO/IO Treatment Regimen for a Patient With RCC - Vimarsana News

Considerations When Deciding Between an IO/TKI and IO/IO Treatment Regimen for a Patient With RCC

Hans Hammers, MD, PhD, explains the situations in which he would choose an ipilimumab/nivolumab treatment regimen over one of the discussed IO/TKI regimens.